Viwat Visuthikraisee

Title: Viwat Visuthikraisee: Innovator in Pharmaceutical Compositions

Introduction

Viwat Visuthikraisee is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing methods to counteract the cardiotoxic effects of chemotherapy. With a total of 4 patents, his work is paving the way for safer cancer treatments.

Latest Patents

One of his latest patents focuses on pharmaceutical compositions and methods for countering chemotherapy-induced cardiotoxicity. This disclosure provides innovative methods and compositions aimed at reducing or eliminating cardiotoxicity, especially that induced by cancer treatments. The methods often involve administering protective agents such as myricetin, tricetin, robinetin, ficetin, vitexin, quercetin, dihydrorobinetin, kaempferol, and others in conjunction with cancer drugs. These compositions may also include co-formulations with dexrazoxane, enhancing the efficacy of cancer treatments while minimizing harmful side effects.

Career Highlights

Viwat has worked with several companies, including Auransa Inc. and Sct II LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations. His work is characterized by a commitment to improving patient outcomes through scientific advancements.

Collaborations

Throughout his career, Viwat has collaborated with notable professionals in the field, including Christopher G. Armstrong and Kevin J. Kim. These collaborations have further enriched his research and development efforts.

Conclusion

Viwat Visuthikraisee stands out as an influential inventor in the pharmaceutical industry. His innovative approaches to mitigating chemotherapy-induced cardiotoxicity reflect his dedication to enhancing cancer treatment safety. His contributions are vital in the ongoing quest for better healthcare solutions.